Huron Corp (HURN) - Kompaniya qiymatining sof foydaga nisbati

Huron Consulting - HURN emitenti grafik logotipi

Huron Consulting Group (HURN) ma'lumotlar tahlili uchun AI platformalarini yaratish orqali sog'liqni saqlash boshqaruvi sohasida ilg'or IT innovatsiyalarini joriy qilmoqda. P/E koeffitsiyenti dinamikasi biznes qiymatini uning daromadlariga nisbatan baholashga yordam beradi, 23.50 darajasi esa joriy miqdorni aks ettiradi. Kompaniya shifoxonalarni modernizatsiya qilish uchun intiluvchan tahlilchilarni ishga olmoqda, shu bilan birga mijozlar foydasini optimallashtirish uchun bashoratli tahlil dasturiy modullarini ishlab chiqmoqda.

huronconsultinggroup.com (HURN): Narxning foydaga nisbati 04.07.2022dan 14.11.2026gacha

Huron Consulting Group kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning umumiy tahlili:huronconsultinggroup.com - HURN
huronconsultinggroup.com original mahsuloti

P/E koeffitsiyenti bir dollar foydaning tannarxini o'lchaydi va aktivning joriy narxi bilan kelajakdagi daromadlar bo'yicha bozor kutganlari o'rtasidagi muvozanatni aks ettiradi. Kompaniyaning maqsadli P/E koeffitsiyentini tahlil qilish orqali investor foyda premiumining asoslanganligini baholaydi, bu esa Huron Consulting Group (HURN) uchun kirishdagi yuqori tartibga soluvchi to'siqlar va AQSh davlat sektorida IT ekspertizasini almashtirishning murakkabligi bilan asoslanadi.

Muhim raqobatchilar

Narx-foyda multiplikatori VEEV (veeva.com)|P/E multiplikatori DOCS|HQY (HealthEquity Inc) - Kompaniya qiymatining sof foydaga nisbati|Waystar Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori CorVel Corp. CRVL|PRVA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CERT (certara.com)|Omnicell (OMCL) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati GoodRx Inc (GDRX)|Narxning foydaga nisbati Schrödinger Inc.|Narx-foyda multiplikatori PHR (Phreesia Health)|Narx-foyda koeffitsiyenti OMDA (Omada Health Inc)|EVH (evolenthealth.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori HSTM (HealthStream)|DH - Narx-foyda koeffitsiyenti|CCSI - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Agilon Health Corp|Absci (ABSI) - Narxning foydaga nisbati|Narx-foyda multiplikatori SY|Narxning foydaga nisbati National Research Corporation|Spok Holdings Inc (SPOK) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti OPRX (OptimizeRx Corp.)|P/E multiplikatori TruBridge Corp (TBRG)|Narxning foydaga nisbati Simulations Plus, Inc. SLP|Sophia Genetics - Narxning foydaga nisbati|HCAT: Narx-foyda koeffitsiyenti|CareCloud, Inc. - Bozor narxining sof foydaga nisbati|RSSS: P/E multiplikatori|DLHC - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati OneMedNet Corp|Narx-foyda multiplikatori SCNX (scienture.com)|P/E multiplikatori HCTI|ispecimen.com (ISPC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Bullfrog AI - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WORX|MSP Recovery Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti iCoreConnect Inc. (ICCT)|TRxADE HEALTH (MEDS) - Narxning foydaga nisbati|Orgenesis Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati R1 RCM, Inc.|Kapitalizatsiyaning foydaga nisbati Sharecare Inc SHCR|Narx-foyda koeffitsiyenti STRM (Streamline Health Solutions)|P/E multiplikatori syrahealth.com (SYRA)|Narxning foydaga nisbati Apollo Medical Holdings, Inc. AMEH|MODN (Model N Inc) - Kapitalizatsiyaning sof foydaga nisbati|NextGen - P/E multiplikatori